In the BioHarmony Drug Report Database

"Preview" Icon

Rilonacept

Arcalyst (rilonacept) is a protein pharmaceutical. Rilonacept was first approved as Arcalyst on 2008-02-27. It is used to treat inborn genetic diseases and inflammation in the USA. The pharmaceutical is active against interleukin-1 beta.

 

Trade Name

 

Arcalyst
 

Common Name

 

rilonacept
 

ChEMBL ID

 

CHEMBL1201830
 

Indication

 

inborn genetic diseases, inflammation
 

Drug Class

 

Receptor molecules, native or modified: interleukins

Image (chem structure or protein)

Rilonacept structure rendering